{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:39:25Z","timestamp":1791725965232,"version":"4.3.4"},"reference-count":26,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.6002\/ect.2022.0269","type":"journal-issue","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T09:18:26Z","timestamp":1666171106000},"source":"Crossref","is-referenced-by-count":2,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Davidson JA, Wilkinson A. New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care. 2004;27(3):805-812. doi:10.2337\/diacare.27.3.805","DOI":"10.2337\/diacare.27.3.805"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Porrini EL, D\u00edaz JM, Moreso F, et al. Clinical evolution of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2016;31(3):495-505. doi:10.1093\/ndt\/gfv368","DOI":"10.1093\/ndt\/gfv368"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002;62(4):1440-1446. doi:https:\/\/doi.org\/10.1111\/j.1523-1755.2002.kid582.x","DOI":"10.1111\/j.1523-1755.2002.kid582.x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Yates CJ, Fourlanos S, Hjelmes\u00e6th J, Colman PG, Cohney SJ. New-onset diabetes after kidney transplantation-changes and challenges. Am J Transplant. 2012;12(4):820-828. doi:https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03855.x","DOI":"10.1111\/j.1600-6143.2011.03855.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sharif A, Hecking M, de Vries APJ, et al. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions. Am J Transplant. 2014;14(9):1992-2000. doi:https:\/\/doi.org\/10.1111\/ajt.12850","DOI":"10.1111\/ajt.12850"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4(4):583-595. doi:10.1046\/j.1600-6143.2003.00372.x","DOI":"10.1046\/j.1600-6143.2003.00372.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis. 2004;43(6):953-965. doi:10.1053\/j.ajkd.2004.03.020","DOI":"10.1053\/j.ajkd.2004.03.020"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Sharif A, Baboolal K. Risk factors for new-onset diabetes after kidney transplantation. Nat Rev Nephrol. 2010;6(7):415-423. doi:10.1038\/nrneph.2010.66","DOI":"10.1038\/nrneph.2010.66"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216. doi:10.1038\/s41392-022-01073-0","DOI":"10.1038\/s41392-022-01073-0"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007\/s11906-018-0812-z","DOI":"10.1007\/s11906-018-0812-z"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Oterdoom LH, de Vries APJ, Gansevoort RT, et al. Determinants of insulin resistance in renal transplant recipients. Transplantation. 2007;83(1):29-35. doi:10.1097\/01.tp.0000245844.27683.48","DOI":"10.1097\/01.tp.0000245844.27683.48"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Porrini E, Delgado P, Alvarez A, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transpl. 2008;23:1436-1441. doi:10.1093\/ndt\/gfm762","DOI":"10.1093\/ndt\/gfm762"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Rodriguez-Rodriguez AE, Tri\u00f1anes J, Velazquez-Garcia S, et al. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. Am J Transplant. 2013;13(7):1665-1675. doi:10.1111\/ajt.12236","DOI":"10.1111\/ajt.12236"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Tri\u00f1anes J, Rodriguez-Rodriguez AE, Brito-Casillas Y, et al. Deciphering tacrolimus-induced toxicity in pancreatic \u03b2 cells. Am J Transplant. 2017;17(11):2829-2840. doi:10.1111\/ajt.14323","DOI":"10.1111\/ajt.14323"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Rodriguez-Rodriguez AE, Porrini E, Torres A. Beta-cell dysfunction induced by tacrolimus: a way to explain type 2 diabetes? Int J Mol Sci. 2021;22(19)10311. doi:10.3390\/ijms221910311","DOI":"10.3390\/ijms221910311"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Scorletti E, Carr RM. A new perspective on NAFLD: Focusing on lipid droplets. J Hepatol. 2022;76(4):934-945. doi:10.1016\/j.jhep.2021.11.009","DOI":"10.1016\/j.jhep.2021.11.009"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Li X, Song J, Zhang L, et al. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes. 2009 Oct;58(10):2246-2257. doi:10.2337\/db08-1512.","DOI":"10.2337\/db08-1512"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Thiam AR, Beller M. The why, when and how of lipid droplet diversity. J Cell Sci. 2017;130(2):315-324. doi:10.1242\/jcs.192021","DOI":"10.1242\/jcs.192021"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Fu Z, R. Gilbert E, Liu D. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2012;9(1):25-53. doi:10.2174\/157339913804143225","DOI":"10.2174\/157339913804143225"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Lee J, Homma T, Kurahashi T, Kang ES, Fujii J. Oxidative stress triggers lipid droplet accumulation in primary cultured hepatocytes by activating fatty acid synthesis. Biochem Biophys Res Commun. 2015;464(1):229-235. doi:10.1016\/j.bbrc.2015.06.121","DOI":"10.1016\/j.bbrc.2015.06.121"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Petan T, Jarc E, Jusovi\u0107 M. Lipid droplets in cancer: guardians of fat in a stressful world. Molecules. 2018;23(8):1941. doi:10.3390\/molecules23081941","DOI":"10.3390\/molecules23081941"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Rambold AS, Cohen S, Lippincott-Schwartz J. Fatty acid trafficking in starved cells: Regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell. 2015;32(6):678-692. doi:10.1016\/j.devcel.2015.01.029","DOI":"10.1016\/j.devcel.2015.01.029"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Bailey AP, Koster G, Guillermier C, et al. Antioxidant role for lipid droplets in a stem cell niche of Drosophila. Cell. 2015;163(2):340-353. doi:10.1016\/j.cell.2015.09.020","DOI":"10.1016\/j.cell.2015.09.020"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Liu L, Zhang K, Sandoval H, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160(1-2):177-190. doi:10.1016\/j.cell.2014.12.019","DOI":"10.1016\/j.cell.2014.12.019"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Oh YS, Bae GD, Baek DJ, Park EY, Jun HS. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol (Lausanne). 2018;9:1-10. doi:10.3389\/fendo.2018.00384","DOI":"10.3389\/fendo.2018.00384"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Font\u00e9s G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 2010;1801(3):289-298. doi:10.1016\/j.bbalip.2009.08.006","DOI":"10.1016\/j.bbalip.2009.08.006"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:07:01Z","timestamp":1776431221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2026\/24\/3\/0\/237\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2022.0269","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}